MarketPulse — Real-Time Financial News & Market Analysis

Latest News

8,874 articles
Mon, Mar 23
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

ELWT Plunges on Accounting Restatement; Class Action Investigation Launched

Elauwit Connection ($ELWT) stock fell 6.8% after disclosing revenue recognition errors in its Q3 2025 filing. Securities litigation firm investigating potential class action claims.
ELWTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Class Action Against ODDITY Tech Over Alleged Ad Algorithm Misstatements

Rosen Law Firm launches securities class action against ODDITY Tech ($ODD) for allegedly misleading investors about algorithm changes affecting customer acquisition costs.
ODDsecurities fraudclass action lawsuit
BenzingaBenzinga··Chris Katje

Trump's Iran Strikes Trigger Approval Slump as Markets Tumble on Geopolitical Risk

Trump's approval rating falls to 42% after Iran military strikes. Voters oppose action; S&P 500 drops below $650 amid Middle East tensions and oil price surge.
SPYoil pricesstock market decline
GlobeNewswire Inc.GlobeNewswire Inc.··Na

GAP Refinances $1.12B Maturing Bonds Through Scotiabank Credit Facility

Grupo Aeroportuario del Pacífico refinances maturing bond certificates worth Ps.1,120 million through new 12-month Scotiabank facility at TIIE Funding plus 44 basis points.
PACcredit facilitydebt refinancing
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

iDox.ai Launches Guardrail Platform to Combat AI Agent Security Vulnerabilities

iDox.ai launches Guardrail AI governance platform with real-time monitoring to prevent autonomous agent security vulnerabilities like those exposed by OpenClaw research.
NVDAAI agentscompliance
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

REGENXBIO Faces Securities Lawsuit Over Gene Therapy Trial Disclosures

Rosen Law Firm recruits investors for securities class action against REGENXBIO over alleged RGX-111 gene therapy misstatements. Lead plaintiff deadline: April 14, 2026.
RGNXsecurities class actionmaterial misstatement
GlobeNewswire Inc.GlobeNewswire Inc.··Fiverr

Fiverr's AI Video Hub Disrupts Hollywood Model With Budget-Friendly Directors

Fiverr launches AI Video Hub with independent directors delivering studio-quality content cheaper and faster than traditional Hollywood, capitalizing on 66% surge in AI video creation demand.
FVRRcost reductionAI tools
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Securities Lawsuit Targets Paysafe Over Alleged Misstatements; Investors Face Filing Deadline

Rosen Law Firm files securities class action against Paysafe Limited, alleging false statements about business operations and financial performance. Investors must act before lead plaintiff deadline.
RGNXODDPSFEsecurities class actionlead plaintiff deadline
The Motley FoolThe Motley Fool··Lawrence Nga

Palantir's Path to AI Dominance: The Bull Case for Enterprise OS Crown

Palantir could become the operating system for enterprise AI through its integrated platform ecosystem, potentially achieving infrastructure-level economics similar to Microsoft over three years.
MSFTPLTRvaluationenterprise AI
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Galapagos and Gilead Team Up on Breakthrough T Cell Engager for Autoimmune Diseases

Galapagos and Gilead plan to jointly develop an Ouro T cell engager for autoimmune diseases, splitting acquisition costs while Galapagos leads development and Gilead commercializes, freeing $500M in Galapagos cash.
GILDGLPGautoimmune diseasesorphan drug designation
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Galapagos, Gilead in Advanced Talks on T-Cell Therapy Partnership

Galapagos and Gilead are in advanced partnership talks for a first-in-class T-cell engager for autoimmune diseases, with 50% cost-sharing and €500 million capital freed for Galapagos.
GILDGLPGstrategic partnershipclinical development
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

$STLA Plunges 23.7% as Law Firm Probes Stellantis for Securities Violations

Law firm investigates Stellantis for potential securities violations after €22.2 billion charge announcement triggers 23.7% stock plunge to $7.28.
STLAsecurities investigationstock price decline
The Motley FoolThe Motley Fool··Eric Volkman

Arm Holdings Surges on AI Chiplet Ambitions Ahead of Product Reveal

Arm Holdings stock rises 3% ahead of March 24 product event as Morgan Stanley predicts AI chiplet announcement targeting cloud computing customers.
MSFTAMZNARMcloud computingmorgan-stanley
The Motley FoolThe Motley Fool··Emma Newbery

Airlines Soar as Geopolitical Tensions Ease, Oil Prices Drop

Airlines rally on easing Iran tensions and declining oil prices. AAL up 3.64% to $10.81, though down 16% monthly amid persistent volatility.
DALUALAALoil pricesgeopolitical risk
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Kyndryl Faces Securities Class Action Over False Financial Disclosures

Rosen Law Firm urges Kyndryl investors to retain counsel before April 13, 2026 deadline in securities class action over false financial disclosures.
KDsecurities class actionlead plaintiff deadline
BenzingaBenzinga··Chris Katje

Congressman Dumps Warner Bros. Discovery Stock Despite 150% Gain Amid Merger Review

Rep. Pfluger sells Warner Bros. Discovery stock despite 150% annual gain amid DOJ review of Paramount-Skydance merger.
NFLXWBDParamount SkydanceWarner Bros. Discovery
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Coty Faces Securities Lawsuit Over Undisclosed Business Deterioration

Securities class action filed against $COTY for failing to disclose weakness in beauty and fragrance segments. Stock fell 22% following disappointing Q2 results and guidance withdrawal.
COTYstock declineearnings miss
The Motley FoolThe Motley Fool··Todd Shriber

Blue Owl Crisis Triggers BDC Selloff—But BIZD Offers Bargain for Risk-Tolerant Investors

VanEck BDC Income ETF down 12% in 2026 as private credit turmoil spreads. BDCs trade at steep discounts to book value, potentially presenting opportunity.
OBDCBIZDhigh-yield ETFprivate credit
BenzingaBenzinga··Not Specified

Outlook Therapeutics Launches Capital Raise Through Public Stock Offering

Outlook Therapeutics launches best-efforts public offering of stock and warrants with H.C. Wainwright as placement agent, subject to market conditions.
OTLKwarrantspublic offering
The Motley FoolThe Motley Fool··Eric Volkman

Grocery Outlet CEO's $1.7M Share Purchase Ignites 11% Stock Rally

Grocery Outlet CEO buys $1.7M in stock, doubling stake as company faces comparable sales decline and launches 36-store closure plan.
GOcomparable sales declineinsider buying